Our specialized programs include:
- The Congenital Adrenal Hyperplasia and Disorders of Sex Development, where expert healthcare professionals from multiple disciplines offer state-of-the-art patient-oriented care and cutting-edge research in personalized therapy and monitoring in children with these rare disorders.
- The Comprehensive Pediatric Bone Health Program provides patient- and family-focused care and offers access to the latest research studies focusing on the prevention, diagnosis and treatment of bone diseases in children.
- The thyroid program offers specialty care for patients with thyroid nodules and thyroid cancer.
- The neurooncology program provides children and families with neurofibromatosis, pituitary and brain tumors comprehensive medical care involving a multi-disciplinary team including neurooncology, endocrinology, neurosurgery, neuropathology and neuroradiology that work together to identify the best treatment and monitoring plan for each child.
- The growth program offers comprehensive care for children with rare growth disorders including Russell-Silver, Noonan, cardiofaciocutaneous, Prader Willi and Turner syndromes. Children with growth disorders have access to clinical trials involving the latest growth therapies.
- We are the leading site for the Lysosomal Disease Network, an international network of clinicians involved in clinical care and research involving rare disorders including the mucopolysaccharidoses. People with these rare disorders have access to specialists in many subspecialties familiar with the nuances of their conditions.
- Our long-term cancer follow-up clinic cares for children and young adults after they have survived cancer and its treatment, including bone marrow transplantation. Endocrine disorders are the most common long-term complication of cancer and its treatment. Our endocrinologists are an integral part of this team.
At University of Minnesota Masonic Children's Hospital, patients have access to leading-edge research studies and investigational therapies for diabetes, growth problems, delayed or early puberty, disorders of sex development, calcium and bone disorders, thyroid and adrenal disease and other endocrine problems. Our clinical investigators are closely involved in research relating to special populations with endocrine disorders such as international adoptees, children who have had cancer treatment, including bone marrow transplantation, children who have pancreatitis and have their pancreatic islets (insulin producing cells) transplanted, children with Fanconi anemia, fetal alcohol syndrome, thyroid nodules, congenital adrenal hyperplasia and disorders of sex development, storage diseases (such as mucopolysaccharisosis and adrenoleokodystrophy) or cystic fibrosis. Pediatric endocrinology care at University of Minnesota Masonic Children’s Hospital has earned numerous accolades over the years, including regular recognition as one of the top programs in the country from U.S. News & World Report. In 2018, U.S. News and World Report once again ranked us among the best in the nation. See our results.